Press release
New Research Study on Osteoporosis - Pipeline Review | Abreos Biosciences, Alvogen Korea Co Ltd, Amgen, Asahi Kasei Corp, BiosanaPharma BV
Osteoporosis - Pipeline Review
Request a sample report @ https://www.htfmarketreport.com/sample-report/1442071-osteoporosis-pipeline-review-5
Summary
Osteoporosis - Pipeline Review, H2 2018
Summary
The latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Pipeline Review, H2 2018, provides an overview of the Osteoporosis (Metabolic Disorders) pipeline landscape.
Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Signs and symptoms include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, a bone fracture that occurs much more easily than expected. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications.
Report Highlights
The Pharmaceutical and Healthcare latest pipeline guide Osteoporosis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Osteoporosis (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 7, 1, 6, 4, 21, 3, 56, 13 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 12 and 12 molecules, respectively.
Osteoporosis (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoporosis (Metabolic Disorders).
- The pipeline guide reviews pipeline therapeutics for Osteoporosis (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Osteoporosis (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Osteoporosis (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Osteoporosis (Metabolic Disorders)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Osteoporosis (Metabolic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Osteoporosis (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Companies Mentioned in the Report
Abreos Biosciences Inc, Alvogen Korea Co Ltd, Amgen Inc, Asahi Kasei Corp, BiosanaPharma BV, Biosion Inc, Bone Biologics Corp, Bristol-Myers Squibb Co, Cadila Healthcare Ltd, ChoDang Pharm Co Ltd, Chugai Pharmaceutical Co Ltd, Corium International Inc, Daewon Pharm Co Ltd, Daiichi Sankyo Co Ltd, Dong Wha Pharma Co Ltd, Eli Lilly and Co, EndoCeutics Inc, Entera Bio Ltd, Enteris BioPharma Inc, Enzene Biosciences Ltd, Enzo Biochem Inc, Evgen Pharma Plc, Gador SA, Genor BioPharma Co Ltd, GL Pharm Tech Corp, GlycoNex Inc, Hanmi Pharmaceuticals Co Ltd, Haoma Medica Ltd, Huons Global Co Ltd, Immunwork Inc, Innovent Biologics Inc, InSight Biopharmaceuticals Ltd, Intas Pharmaceuticals Ltd, Ipsen SA, JHL Biotech Inc, Jiangsu Hengrui Medicine Co Ltd, Lead Discovery Center GmbH, Lotus Pharmaceutical Co Ltd, Lupin Ltd, Luye Pharma Group Ltd, mAbxience SA, Merck & Co Inc, Millendo Therapeutics Inc, Nano Intelligent Biomedical Engineering Corp, Omeros Corp, Oncobiologics Inc, Paras Biopharmaceuticals Finland Oy, Pfenex Inc, PhytoHealth Corp, R Pharm, Reliance Life Sciences Pvt Ltd, Ribomic Inc, Richter Gedeon Nyrt, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Shenzhen Salubris Pharmaceuticals Co Ltd, Shin Poong PharmCo Ltd, Sinil Pharmaceutical Co Ltd, Stelis Biopharma Pvt Ltd, Terpenoid Therapeutics Inc, TSH Biopharm Corporation Ltd, Uni-Bio Science Group Ltd, Viking Therapeutics Inc, ViroMed Co Ltd, Wroclawskie Centrum Badan EIT+ Sp z oo, Yooyoung Pharm Co Ltd
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/1442071-osteoporosis-pipeline-review-5
Table of Contents
Table of Contents 2
Introduction 6
Osteoporosis - Overview 7
Osteoporosis - Therapeutics Development 8
Osteoporosis - Therapeutics Assessment 25
Osteoporosis - Companies Involved in Therapeutics Development 35
Osteoporosis - Drug Profiles 66
Osteoporosis - Dormant Projects 239
Osteoporosis - Discontinued Products 247
Osteoporosis - Product Development Milestones 249
Appendix 258List of Tables
Number of Products under Development for Osteoporosis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and
....Continued
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1442071-osteoporosis-pipeline-review-5
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1442071
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand].
About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com
Connect with us at
www.linkedin.com/company/13388569/
www.facebook.com/htfmarketintelligence/
twitter.com/htfmarketreport
plus.google.com/u/0/+NidhiBhawsar-SEO_Expert?rel=author
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Research Study on Osteoporosis - Pipeline Review | Abreos Biosciences, Alvogen Korea Co Ltd, Amgen, Asahi Kasei Corp, BiosanaPharma BV here
News-ID: 1421714 • Views: …
More Releases from HTF Market Intelligence Consulting Pvt. Ltd.
Organic Electronics Market May Set a New Growth Story | BASF SE, Konica Minolta
According to HTF Market Intelligence, the Global Organic Electronics market to witness a CAGR of 25.30% during the forecast period (2025-2030). The Latest Released Organic Electronics Market Research assesses the future growth potential of the Organic Electronics market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
Automotive Edge Controller Market is Booming Worldwide | Major Giants Denso Corp …
According to HTF Market Intelligence, the Global Automotive Edge Controller market to witness a CAGR of 22.10% during the forecast period (2025-2030). The Latest Released Automotive Edge Controller Market Research assesses the future growth potential of the Automotive Edge Controller market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify…
Green Ethanol Production Market Reaches All-Time High | POET , Archer Daniels Mi …
According to HTF Market Intelligence, the Global Green Ethanol Production market to witness a CAGR of 11.69% during the forecast period (2025-2030). The Latest Released Green Ethanol Production Market Research assesses the future growth potential of the Green Ethanol Production market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify…
Door Hinges Market Is Booming Worldwide | Major Giants Allegion , Stanley Hardwa …
HTF MI recently introduced Global Door Hinges Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market size (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major Companies in Door Hinges Market are: Hettich (Germany), Blum (Austria), Assa Abloy (Sweden), Allegion (US), Stanley Hardware (US), Deltana (US), Sugatsune (Japan),…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
